Found: 133
Select item for more details and to access through your institution.
Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
AutoFocus: a hierarchical framework to explore multi-omic disease associations spanning multiple scales of biomolecular interaction.
- Published in:
- Communications Biology, 2024, p. 1, doi. 10.1038/s42003-024-06724-2
- By:
- Publication type:
- Article
Opioid use affects antioxidant activity and purine metabolism: preliminary results.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2009, v. 24, n. 8, p. 666, doi. 10.1002/hup.1068
- By:
- Publication type:
- Article
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients.
- Published in:
- Translational Psychiatry, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41398-019-0507-5
- By:
- Publication type:
- Article
Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans.
- Published in:
- Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00135
- By:
- Publication type:
- Article
ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01119-z
- By:
- Publication type:
- Article
Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00893-6
- By:
- Publication type:
- Article
Expert insights: The potential role of the gut microbiome‐bile acid‐brain axis in the development and progression of Alzheimer's disease and hepatic encephalopathy.
- Published in:
- Medicinal Research Reviews, 2020, v. 40, n. 4, p. 1496, doi. 10.1002/med.21653
- By:
- Publication type:
- Article
Leveraging Health Linkage Data From the UK Biobank—With Great Power Comes Great Responsibility—Reply.
- Published in:
- JAMA Psychiatry, 2023, v. 80, n. 10, p. 1077, doi. 10.1001/jamapsychiatry.2023.2969
- By:
- Publication type:
- Article
Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replication.
- Published in:
- Translational Psychiatry, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41398-021-01632-z
- By:
- Publication type:
- Article
MiMeDB: the Human Microbial Metabolome Database.
- Published in:
- Nucleic Acids Research, 2023, v. 51, n. D1, p. D611, doi. 10.1093/nar/gkac868
- By:
- Publication type:
- Article
Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review.
- Published in:
- Metabolomics, 2015, v. 11, n. 4, p. 872, doi. 10.1007/s11306-014-0746-7
- By:
- Publication type:
- Article
Introducing the USA Plant, Algae and Microbial Metabolomics Research Coordination Network (PAMM-NET).
- Published in:
- Metabolomics, 2015, v. 11, n. 1, p. 3, doi. 10.1007/s11306-014-0755-6
- By:
- Publication type:
- Article
Interest in metabolomics continues to grow within US National Institutes of Health (NIH).
- Published in:
- Metabolomics, 2012, v. 8, n. 4, p. 754, doi. 10.1007/s11306-012-0444-2
- By:
- Publication type:
- Article
Stable isotope-resolved metabolomic analysis of lithium effects on glial-neuronal metabolism and interactions.
- Published in:
- Metabolomics, 2010, v. 6, n. 2, p. 165, doi. 10.1007/s11306-010-0208-9
- By:
- Publication type:
- Article
Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study.
- Published in:
- Metabolomics, 2010, v. 6, n. 2, p. 191, doi. 10.1007/s11306-010-0207-x
- By:
- Publication type:
- Article
Peripheral inflammation is associated with brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer's disease.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67177-5
- By:
- Publication type:
- Article
Increases in cortical glutamate concentrations in transgenic amyotropic lateral sclerosis mice....
- Published in:
- Journal of Neurochemistry, 2001, v. 77, n. 2, p. 383, doi. 10.1046/j.1471-4159.2001.00188.x
- By:
- Publication type:
- Article
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's disease.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-04011-6
- By:
- Publication type:
- Article
Metabolomics: A Global Biochemical Approach to the Study of Central Nervous System Diseases.
- Published in:
- Neuropsychopharmacology, 2009, v. 34, n. 1, p. 173, doi. 10.1038/npp.2008.174
- By:
- Publication type:
- Article
Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts.
- Published in:
- Scientific Data, 2019, v. 6, n. 1, p. N.PAG, doi. 10.1038/s41597-019-0181-8
- By:
- Publication type:
- Article
Metabolomics Standards Workshop and the development of international standards for reporting metabolomics experimental results.
- Published in:
- Briefings in Bioinformatics, 2006, v. 7, n. 2, p. 159, doi. 10.1093/bib/bbl008
- By:
- Publication type:
- Article
Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study.
- Published in:
- Psychopharmacology, 2009, v. 206, n. 3, p. 479, doi. 10.1007/s00213-009-1625-1
- By:
- Publication type:
- Article
Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis.
- Published in:
- Frontiers in Cellular Neuroscience, 2013, v. 7, p. 1, doi. 10.3389/fncel.2013.00090
- By:
- Publication type:
- Article
The Metabolomics Standards Initiative.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Correction to: Sex and race differences of cerebrospinal fluid metabolites in healthy individuals.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Sex and race differences of cerebrospinal fluid metabolites in healthy individuals.
- Published in:
- Metabolomics, 2021, v. 17, n. 2, p. 1, doi. 10.1007/s11306-020-01757-0
- By:
- Publication type:
- Article
Quality Assurance of Metabolomics.
- Published in:
- Altex, 2015, v. 32, n. 4, p. 319, doi. 10.14573/altex.1509161
- By:
- Publication type:
- Article
Integrative metabolomics‐genomics approach reveals that pathways related to the metabolism of acylcarnitines and amines are new potential targets of Alzheimer's disease: Genome‐metabolome‐phenome: Towards an integrated molecular atlas for Alzheimer's disease
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045610
- By:
- Publication type:
- Article
A network‐based, multi‐omics atlas for target identification and prioritization in Alzheimer's disease: Genome‐metabolome‐phenome: Towards an integrated molecular atlas for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045594
- By:
- Publication type:
- Article
Serum metabolome informs neuroimaging biomarkers for Alzheimer's disease: Genome‐metabolome‐phenome: Towards an integrated molecular atlas for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045596
- By:
- Publication type:
- Article
Hallmarks of late‐onset Alzheimer's disease in a humanized mouse model: Development of new models and analysis methods/screening studies/platforms.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045162
- By:
- Publication type:
- Article
Clostridium shows a higher abundance in less neurovascular and neurodegenerative changes: A microbiome‐wide association study: Genetics/omics and systems biology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044743
- By:
- Publication type:
- Article
Discovery of SLC16A9 and SLC22A1 as regulators of acylcarnitines associated with Alzheimer's disease: Genetics/genetic factors of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043411
- By:
- Publication type:
- Article
The role of the gut microbiome in cognitive function and Alzheimer's disease: Biomarkers (non‐neuroimaging) / Novel biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043197
- By:
- Publication type:
- Article
Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 9, p. 1234, doi. 10.1002/alz.12110
- By:
- Publication type:
- Article
P4‐116: SERUM TRIGLYCERIDES IN ALZHEIMER'S DISEASE: RELATION TO NEUROIMAGING, CSF, AND GENETIC VARIATION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1320, doi. 10.1016/j.jalz.2019.06.3777
- By:
- Publication type:
- Article
P2‐153: METABOLOMICS‐GENOMICS INTEGRATIVE APPROACH REVEALED NEW CANDIDATE GENES RELATED TO ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P634, doi. 10.1016/j.jalz.2019.06.2560
- By:
- Publication type:
- Article
P1‐386: ASSOCIATION OF SERUM‐BASED PLASMALOGENS WITH NEUROIMAGING AND GENETIC VARIATION IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P403, doi. 10.1016/j.jalz.2019.06.941
- By:
- Publication type:
- Article
P4‐099: MULTIVARIATE CLUSTER PROFILING OF AMYLOID BETA, TAU, NEURODEGENERATION AND VASCULAR (ATNV) BIOMARKERS IN THE ADNI COHORT: IMPLICATIONS FOR COGNITION, –OMICS AND CLINICAL TRIALS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1475, doi. 10.1016/j.jalz.2018.06.2502
- By:
- Publication type:
- Article
P3‐069: CHOLESTEROL EFFLUX CAPACITY (CEC) IN PLASMA AND CEREBROSPINAL FLUID (CSF) OF PATIENTS WITH ALZHEIMER'S DISEASE (AD) AND MILD COGNITIVE IMPAIRMENT (MCI) AND COMPARISON SUBJECTS: EFFECTS OF GENDER AND DIAGNOSIS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1090, doi. 10.1016/j.jalz.2018.06.1425
- By:
- Publication type:
- Article
F3‐02‐04: SERUM INDICES OF ETHANOLAMINE PLASMALOGENS AND PHOSPHATIDE METABOLISM IN THE COMBINED ADNI‐1/GO/2 COHORT: DOES THE LIVER CONTRIBUTE TO AD RISK BY FAILING TO SUPPLY KEY LIPIDS TO THE BRAIN?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P998, doi. 10.1016/j.jalz.2018.06.2747
- By:
- Publication type:
- Article
F3‐02‐03: ASSOCIATION OF SERUM LIPIDS WITH ALZHEIMER'S DISEASE IN THE ADNI COHORT: AN UNTARGETED LIPIDOMICS STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P998, doi. 10.1016/j.jalz.2018.06.2746
- By:
- Publication type:
- Article
F3‐02‐02: CIRCULATING METABOLITES' ASSOCIATION WITH ALZHEIMER'S DISEASE–ASSOCIATED GENETIC VARIANTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P997, doi. 10.1016/j.jalz.2018.06.2745
- By:
- Publication type:
- Article
F3‐02‐01: ALTERED BILE ACID METABOLITES IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE: RELATION TO NEUROIMAGING AND CSF BIOMARKERS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P997, doi. 10.1016/j.jalz.2018.06.2744
- By:
- Publication type:
- Article
P2‐261: APOLIPOPROTEIN J/CLUSTERIN IS THE PRIMARY DETERMINANT OF THE CHOLESTEROL EFFLUX CAPACITY OF CEREBROSPINAL FLUID.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P776, doi. 10.1016/j.jalz.2018.06.950
- By:
- Publication type:
- Article
P2‐253: EP300 IS ASSOCIATED WITH ALTERED BILE ACIDS IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P772, doi. 10.1016/j.jalz.2018.06.942
- By:
- Publication type:
- Article
P1‐153: DIACYLGLYCEROL PATHWAY‐RELATED GENE PNPLA2 IS ASSOCIATED WITH CSF BIOMARKERS IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P335, doi. 10.1016/j.jalz.2018.06.157
- By:
- Publication type:
- Article